135 related articles for article (PubMed ID: 19802974)
1. Comparative in-vitro activity of ceftazidime (GR-20263) and other beta-lactamase stable cephalosporins against anaerobic bacteria.
Chow AW; Bartlett KH
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():91-5. PubMed ID: 19802974
[TBL] [Abstract][Full Text] [Related]
2. Ceftazidime: in-vitro antibacterial activity and susceptibility to beta-lactamases compared with that of cefotaxime, moxalactam and other beta-lactam antibiotics.
Phillips I; Warren C; Shannon K; King A; Hanslo D
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():23-31. PubMed ID: 19802967
[TBL] [Abstract][Full Text] [Related]
3. Comparative in-vitro activity of ceftazidime (GR 20263) and other beta-lactamase stable cephalosporins against pseudomonas. Effect of inoculum size and divalent cation supplementation.
Chow AW; Bartlett KH
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():345-8. PubMed ID: 19803012
[TBL] [Abstract][Full Text] [Related]
4. Susceptibility of ceftazidime and other cephalosporins to a range of beta-lactamases and their potential as inducing agents.
Mouton RP; Bongaerts GP; van Gestel MH
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():147-52. PubMed ID: 19802978
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of cefoxitin and parenterally administered cephalosporins against anaerobic bacteria.
Sutter VL; Kirby B; Finegold SM
Rev Infect Dis; 1979; 1(1):218-23. PubMed ID: 318226
[TBL] [Abstract][Full Text] [Related]
6. Influence of bacterial beta-lactamase production on susceptibility in agar or broth to new cephalosporins.
Adamsson L; Dornbusch K; Hallander HO
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():153-62. PubMed ID: 19802979
[TBL] [Abstract][Full Text] [Related]
7. Comparative in vitro activity of 1-oxa-beta-lactam (LY127935) and cefoperazone with other beta-lactam antibiotics against anaerobic bacteria.
Borobio MV; Aznar J; Jimenez R; Garcia F; Perea EJ
Antimicrob Agents Chemother; 1980 Feb; 17(2):129-31. PubMed ID: 6247966
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of ceftazidime and ceftriaxone.
Keenholtz SL; Jacobus NV; Tally FP; Gorbach SL
Clin Ther; 1983; 5(6):603-16. PubMed ID: 6313195
[TBL] [Abstract][Full Text] [Related]
9. Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility tests.
Jones RN; Barry AL; Thornsberry C; Gerlach EH; Fuchs PC; Gavan TL; Sommers HM
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():187-211. PubMed ID: 19802985
[TBL] [Abstract][Full Text] [Related]
10. In-vitro studies with ceftazidime against aerobic gram-negative bacilli and Bacteroides fragilis group.
Acuna G; Johnston J; Young LS; Martin WJ
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():83-9. PubMed ID: 19810170
[TBL] [Abstract][Full Text] [Related]
11. In-vitro activity and beta-lactamase stability of Sch 29482, a penem antibiotic. Comparisons with ceftazidime and moxalactam.
Dornbusch K; Adamsson L; Gezelius L; Hallander H
J Antimicrob Chemother; 1982 Feb; 9 Suppl C():113-21. PubMed ID: 6460739
[No Abstract] [Full Text] [Related]
12. In-vitro activity of ceftazidime, a beta-lactamase stable cephalosporin.
Neu HC
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():131-4. PubMed ID: 19810175
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of flomoxef compared to moxalactam, cefoxitin, cefotaxime, and clindamycin against anaerobes.
Werner H; Heizmann W; Luft G
Arzneimittelforschung; 1988 Nov; 38(11):1553-6. PubMed ID: 3214438
[TBL] [Abstract][Full Text] [Related]
14. In-vitro activity of ceftazidime compared with other beta-lactam antibiotics.
Clarke AM; Zemcov SJ
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():57-62. PubMed ID: 19810169
[TBL] [Abstract][Full Text] [Related]
15. Comparative activity of ceftazidime and four other cephalosporins against gram-negative bacteria and their sensitivity to beta-lactamases.
Galante D; Esposito S; Barba D; Pennucci C; Limauro D; Scioli C
Chemioterapia; 1984 Aug; 3(4):250-4. PubMed ID: 6398123
[TBL] [Abstract][Full Text] [Related]
16. Susceptibility of anaerobic bacteria to Sch 34343 and other antibiotics.
Glupczynski Y; Gordts B; van der Linden MP; Labbé M; Yourassowsky E; Butzler JP
J Antimicrob Chemother; 1985 Jun; 15 Suppl C():193-8. PubMed ID: 4030548
[TBL] [Abstract][Full Text] [Related]
17. Comparison of in vitro activity of GR 20263, a novel cephalosporin derivative, with activities of other beta-lactam compounds.
Wise R; Andrews JM; Bedford KA
Antimicrob Agents Chemother; 1980 May; 17(5):884-9. PubMed ID: 6772097
[TBL] [Abstract][Full Text] [Related]
18. Comparative in-vitro activity of Sch 34343 and other antimicrobial agents against anaerobic bacteria.
Nord CE; Olsson-Liljequist B
J Antimicrob Chemother; 1985 Jun; 15 Suppl C():183-8. PubMed ID: 2863246
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of FK037, a new parenteral cephalosporin, against anaerobic bacteria.
Kato N; Kato H; Tanaka Y; Bando K; Watanabe K; Ueno K
Antimicrob Agents Chemother; 1993 May; 37(5):957-61. PubMed ID: 8517721
[TBL] [Abstract][Full Text] [Related]
20. Comparative in vitro activity of cefbuperazone against anaerobic bacteria isolated from community hospitals.
Goldstein EJ; Citron DM
Antimicrob Agents Chemother; 1985 Feb; 27(2):162-6. PubMed ID: 3985600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
